Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LABCORP HOLDINGS INC. Director's Dealing 2021

Feb 17, 2021

30237_dirs_2021-02-17_29032615-fb5e-434f-97b7-baf786330fd4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2021-02-12

Reporting Person: BERBERIAN LANCE (EVP, CIO & CTO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-12 Common Stock M 234 Acquired 11019 Direct
2021-02-12 Common Stock F 69 $238.26 Disposed 10950 Direct
2021-02-12 Common Stock M 2353 Acquired 13303 Direct
2021-02-12 Common Stock F 699 $238.26 Disposed 12604 Direct
2021-02-12 Common Stock M 353 Acquired 12957 Direct
2021-02-12 Common Stock F 105 $238.26 Disposed 12852 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-02-12 Restricted Stock Unit $ M 234 Disposed Common Stock (234) Direct
2021-02-12 Restricted Stock Unit $ M 2353 Disposed Common Stock (2353) Direct
2021-02-12 Restricted Stock Unit $ M 353 Disposed Common Stock (353) Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2: Stock withholding to satisfy tax withholding obligations.

F3: The Restricted Stock Units vested in three equal annual installments beginning on February 12, 2019 and are now fully vested.

F4: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

F5: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 12, 2020.